drugset / Trial / NCT00115336
Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease
Phase 4
Terminated
10 enrolled
Children's Hospital Medical Center, Cincinnati
National Heart, Lung, and Blood Institute (NHLBI) · collabUniversity of Texas Southwestern Medical Center · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare ketorolac, a potent, non-steroidal anti-inflammatory drug (NSAID), with ibuprofen, a commonly used NSAID, for the treatment of the painful crisis of sickle cell disease (SCD).
Timeline
- Start
- 2005-01
- Primary completion
- 2008-08
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ibuprofen | Small molecule | — | Oral |
| Comparator | Ketorolac | Other / unclassified | — | Intravenous |